Cartesian Therapeutics Cash from Investing (TTM) Insights

Cartesian Therapeutics Inc (RNAC)

25.60 +1.17 (+4.79%) USD | NASDAQ | May 03, 16:00

25.47 -0.13 (-0.51%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2015. Upgrade now.

Date	Value
December 31, 2023	34.61M
September 30, 2023	33.60M
June 30, 2023	3.664M
March 31, 2023	3.577M
December 31, 2022	-15.00M
September 30, 2022	-10.77M
June 30, 2022	17.37M
March 31, 2022	14.85M
December 31, 2021	-17.14M
September 30, 2021	-27.03M
June 30, 2021	-25.51M
March 31, 2021	-23.05M
December 31, 2020	-0.741M
September 30, 2020	-0.584M
June 30, 2020	11.21M
March 31, 2020	16.21M
December 31, 2019	0.229M

Date	Value
September 30, 2019	-0.136M
June 30, 2019	-5.632M
March 31, 2019	8.208M
December 31, 2018	25.27M
September 30, 2018	31.75M
June 30, 2018	23.37M
March 31, 2018	15.38M
December 31, 2017	-2.098M
September 30, 2017	-13.41M
June 30, 2017	-31.25M
March 31, 2017	-35.08M
December 31, 2016	-22.10M
September 30, 2016	-19.80M
June 30, 2016	-0.812M
March 31, 2016	-8.111M
December 31, 2015	-4.679M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-27.03M

Minimum

Sep 2021

34.61M

Maximum

Dec 2023

0.512M

Average

-0.136M

Median

Sep 2019

Cash from Investing (TTM) Benchmarks